BLOG

Does NK Cell Activity Decline With Age? What It Means for Therapy

Published 2026.10.18 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Many people first hear about NK cell therapy while reading about the immune system and wondering why immune defenses seem to weaken over time. A common question is whether age, stress and illness change how well natural killer cells work, and whether that matters when thinking about a cancer immune cell therapy. This article explains what is known in general terms, what is still uncertain, and what to ask a physician. It is general information, not medical advice.

Short answer: NK cell activity can change, but the effect on any one person is uncertain

NK cells are a type of lymphocyte that circulates in the blood and can recognize and attack abnormal cells, including cancer cells and virus-infected cells, without waiting for instructions from other immune cells. Research suggests that NK cell activity tends to decline with age, with chronic stress, and with the effects of cancer itself. However, studies differ in how they measure NK cell activity, and a result in a blood test does not by itself tell a doctor how a particular patient will respond to any treatment.

NK cell therapy is one option that aims to work with the body’s own immunity. At Grand Green Osaka Umekita Clinic, it is offered as a self-pay (non-insured) treatment, and whether it is suitable for you has to be decided after a medical consultation.

Why NK cell activity is discussed in relation to ageing and stress

Even in healthy people, abnormal cells that could develop into cancer are thought to appear regularly. Immune cells, including NK cells, are believed to find and remove many of them in a process called immune surveillance. When immune function is weakened, this process may become less effective, although the exact contribution of NK cells in each person is difficult to measure.

Several factors are often mentioned in the research literature as being associated with lower NK cell activity:

Advancing age, which is linked to gradual changes across the immune system.
Ongoing psychological or physical stress, which may alter immune signaling.
The presence of cancer, which can create conditions that suppress immune cells.
Some cancer treatments, which may temporarily affect blood cell counts.

These are associations seen in studies, not rules that apply to every individual. Lifestyle, other illnesses and medications also play a role, so interpreting your own situation is a job for your doctor.

How NK cell therapy works in outline

In NK cell therapy, a blood sample is taken from the patient. The NK cells are then activated and expanded outside the body at a licensed cell processing facility, and the cultured cells are returned to the patient by intravenous infusion. The aim is to return NK cells that are greater in number and higher in activity, so that weakened immune function may be reinforced.

Because the cells come from the patient, the risk of rejection is considered low. Temporary reactions such as fever or fatigue may occur, and other reactions are possible. The treatment does not require hospitalization, but the schedule, number of infusions and expected course should be confirmed with the treating doctor before starting.

What the evidence can and cannot tell you

It is important to separate two ideas. The first is that NK cell activity can decline. The second is that returning more NK cells will lead to a clinical benefit for a specific person. The first idea has support in the scientific literature. The second is still being studied, and results from laboratory work or early clinical studies cannot be assumed to apply to every patient or every type of cancer.

For this reason, NK cell therapy is not a replacement for standard cancer treatment such as surgery, chemotherapy or radiation therapy. It is discussed as an option that may be considered alongside them, and it does not promise any particular outcome. If you want to look at the primary research yourself, searching PubMed for terms such as natural killer cell, adoptive transfer and ageing is a reasonable starting point, and you can bring what you find to your consultation.

How the therapy is provided in Japan

In Japan, treatments that use processed cells are provided under the Act on the Safety of Regenerative Medicine. Under this system, a clinic submits a treatment plan to the health authorities after it has been reviewed by a certified committee, and cell processing must take place at a facility that meets legal requirements. The therapy is not covered by national health insurance; it is a self-pay treatment, and costs are set by the clinic.

A legal framework does not mean that a treatment is proven to work for every patient. It means that quality control, documentation and reporting are expected. When you consult a clinic, you can ask which plan covers the therapy, where the cells are processed, and how reports of adverse events are handled.

Questions to bring to a consultation in Osaka

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, and an information page for international patients is available in several languages. If you are considering a visit from overseas or from elsewhere in Japan, preparing questions in advance can make the consultation more useful. You may wish to ask:

Why might NK cell therapy be considered in my situation, and what are the limits of the evidence?
How would it fit with my current or planned standard treatment, and can the clinic coordinate with my oncologist?
What are the possible risks and side effects, and what happens if a reaction occurs?
What are the total costs, how many sessions are expected, and over what period?
Who may not be suitable for this therapy?

The final decision should be made with your doctors, taking into account your diagnosis, your health, and your own priorities. Costs, risks, side effects and eligibility are confirmed only through a medical examination and consultation.

Summary

NK cell activity is reported to decline with age, stress and cancer, and NK cell therapy aims to reinforce this part of the immune system by returning expanded, activated NK cells from the patient’s own blood. The scientific picture is still developing, and the therapy is a self-pay option provided under Japan’s regenerative medicine law rather than a substitute for standard treatment. If you are curious, talk with your current doctor and consider a consultation to review the evidence, the risks and the practical details that apply to you.

NK cells, age and therapy

Activity may declineWith age, stress and cancer
Therapy aims to reinforceOwn cells expanded and returned
Alongside standard careNot a replacement
Decide with your doctorCosts, risks and eligibility

This figure is a conceptual summary of the article and does not guarantee any treatment outcome

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›